Akebia Therapeutics
(NASDAQ:AKBA)
$0.406
At close: Aug 17
$0.414
0.0080[1.97%]
PreMarket: 6:56AM EDT
Day High/Low- - -
52 Week High/Low0.3 - 2.93
Open / Close- / -
Float / Outstanding181.9M / 183.8M
Vol / Avg.17K / 9.7M
Mkt Cap74.6M
P/E-
50d Avg. Price0.4
Div / Yield-
Payout Ratio-
EPS0.16
Total Float181.9M

Akebia Therapeutics (NASDAQ:AKBA), Quotes and News Summary

Akebia Therapeutics (NASDAQ: AKBA)

Day High/Low- - -
52 Week High/Low0.3 - 2.93
Open / Close- / -
Float / Outstanding181.9M / 183.8M
Vol / Avg.17K / 9.7M
Mkt Cap74.6M
P/E-
50d Avg. Price0.4
Div / Yield-
Payout Ratio-
EPS0.16
Total Float181.9M
Sector: Health Care.Industry: Biotechnology
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-03
REV
Q2 2022Est.ActualSurprise
EPS-0.3100.230 0.5400
REV49.730M126.759M77.029M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Akebia Therapeutics Questions & Answers

Q
How do I buy Akebia Therapeutics (AKBA) stock?
A

You can purchase shares of Akebia Therapeutics (NASDAQ: AKBA) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Akebia Therapeutics's (AKBA) competitors?
Q
What is the target price for Akebia Therapeutics (AKBA) stock?
A

The latest price target for Akebia Therapeutics (NASDAQ: AKBA) was reported by HC Wainwright & Co. on Monday, May 16, 2022. The analyst firm set a price target for 1.25 expecting AKBA to rise to within 12 months (a possible 207.88% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Akebia Therapeutics (AKBA)?
A

The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $0.406 last updated August 17, 2022, 8:00 PM UTC.

Q
Does Akebia Therapeutics (AKBA) pay a dividend?
A

There are no upcoming dividends for Akebia Therapeutics.

Q
When is Akebia Therapeutics (NASDAQ:AKBA) reporting earnings?
A

Akebia Therapeutics’s Q3 earnings are confirmed for Thursday, November 3, 2022.

Q
Is Akebia Therapeutics (AKBA) going to split?
A

There is no upcoming split for Akebia Therapeutics.

Q
What sector and industry does Akebia Therapeutics (AKBA) operate in?
A

Akebia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.